Oxycodone 20mg
Main Image

Oxycodone 20mg

£7.89

Oxycodone 20mg – The Complete Medical Guide

Oxycodone 20mg is a high-potency immediate-release opioid analgesic classified as a Schedule II controlled substance. This intermediate-strength tablet is prescribed for moderate to severe acute pain in opioid-tolerant patients, typically following major surgeries, traumatic injuries, or for cancer pain management. With 1.5 times the potency of oral morphine, it requires careful clinical oversight due to risks of respiratory depression, misuse, and addiction.

Oxycodone 20mg

Oxycodone 20mg HCl tablets contain Oxycodone (K 57 grey round pill), a narcotic agonist medication used in adults to manage pain severe enough to require narcotic treatment. It works in the brain to change your body’s emotions and stress response. Oxycodone HCl Controlled-Delivery Tablets are narcotic pain relievers available in 10 mg and 20 mg tablets for oral administration. The pill size indicates how much Oxycodone is in each tablet as the hydrochloride salt.
Oxycodone hydrochloride is a white, odorless glassy powder derived from the opium alkaloid, thebaine. 20 milligram Oxycodone is highly soluble in water (1 g per 6 to 7 mL) and is considered soluble in alcohol (octanol water fragment coefficient is 0.7). Each oral tablet contains 5 mg, 10 mg, 15 mg, 20 mg, or 30 mg Oxycodone.
Oxycodone pill has the potential for dependence and is prescribed as a controlled substance. The side effects of K 57 pill are similar to those of other prescription drugs. Disruption is the most widespread and unwanted. The strength of these unpleasant effects decreases after a while.
Patients on Oxy pills should be monitored for withdrawal, help with discomfort, side effects, and proper use. Their pulse and breathing should also be monitored, especially in the first 24 to 72 hours after starting treatment or increasing the dose. Considering that the pain continues to increase after the comparison of the dose, the doctor should investigate the selected causes of the increase before increasing the dose of the drug or returning it. In case of adverse effects, consider a dose reduction to achieve the appropriate level of treatment without side effects.

Medical Uses & Indications

FDA-Approved Uses

 Moderate to severe acute pain in opioid-tolerant patients
 Postoperative pain (Major procedures)
 Trauma-related pain (Fractures, severe injuries)
 Breakthrough cancer pain

Key Clinical Features

• Onset: 15-30 minutes (oral administration)
• Peak effect: 1-2 hours
• Duration: 4-6 hours
• Equianalgesic potency: 20mg ≈ 30mg oral morphine
• DEA Classification: Schedule II controlled substance

Pharmacology & Mechanism

Neurochemical Action

• Full μ-opioid receptor agonist
• κ-opioid receptor partial agonist
• Inhibits ascending pain pathways

Metabolic Profile

• Hepatic metabolism: CYP3A4 (major), CYP2D6 (minor)
• Active metabolite: Oxymorphone (via CYP2D6)
• Elimination half-life: 3-5 hours

Dosing & Administration

Standard Dosing Protocol

• Opioid-tolerant adults:

  • Initial: 10-15mg every 4-6 hours as needed

  • May titrate to 20mg if lower doses ineffective

• Maximum daily dose:

  • 80mg without specialist consultation

Administration Guidelines

• Take whole with water
• May take with food if nausea occurs
• Avoid alcohol completely
• Store securely at room temperature

Critical Safety Notes

 Not for opioid-naïve patients
 Requires opioid tolerance confirmation
 Never crush/chew tablets
 Naloxone co-prescription mandatory

Safety Profile

Common Adverse Effects

• Constipation (prophylactic management required)
• Nausea/vomiting (30-40% incidence)
• Dizziness/sedation
• Pruritus (20-25%)

Black Box Warnings

 Addiction, abuse, and misuse risk
 Life-threatening respiratory depression
 Accidental ingestion danger
 Neonatal opioid withdrawal syndrome

Risk Mitigation Strategies

Prescribing Safeguards

  1. PDMP review before each prescription

  2. Written treatment agreement

  3. Limit to shortest effective duration

  4. Frequent follow-up assessments

Patient Monitoring

• Weekly visits for new starts
• Urine drug screening
• Pill counts for chronic users

Clinical Alternatives

For Moderate-Severe Pain

• Hydrocodone 10mg combinations
• Morphine sulfate IR
• Hydromorphone IR

Non-Opioid Options

• Ketorolac limited course
• Diclofenac sodium
• Lidocaine patches

Special Populations

Population Dosing Considerations Monitoring
Elderly (≥65) 50% dose reduction Increased fall risk
Hepatic impairment Avoid or 75% reduction LFT monitoring
Renal (CrCl<30) Extended interval (q8h) Renal function
Pediatric CONTRAINDICATED
Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:
Uncategorized
Reviews:
(0 customer reviews)
Chat on WhatsApp